Alzheimer'S Disease Clinical Trials in Dallas, TX

Alzheimer'S Disease Clinical Trials in Dallas, TX

View the best 10 alzheimer's disease medical studies in Dallas, Texas. Access promising new therapies by applying to a Dallas-based Alzheimer'S Disease clinical trial.

Trials in Dallas, Texas

Here are the top 10 medical studies for alzheimer's disease in Dallas, Texas

Image of Novo Nordisk Investigational Site in Lomita, United States.

Semaglutide

Glucagon-like peptide-1 (GLP-1) receptor agonist

Recruiting1 awardPhase 3
This trial is to test whether the medication semaglutide has a positive effect on early Alzheimer's disease. The study will last for up to 173 weeks, and participants will have 17 clinic visits and 1 phone call with the study doctor. The study includes various tests and scans, and at 10 of the clinic visits participants will have blood samples taken. The trial is only for women.
Image of MDFirst Research in Chandler, United States.

Simufilam

Recruiting1 awardPhase 3
This trial tests simufilam, a pill taken twice daily, on people with mild-to-moderate Alzheimer's disease. The goal is to see if it can improve memory and slow down the worsening of symptoms by helping the brain work better and reducing harmful swelling. The study will last for about a year and involve periodic check-ups to monitor safety and effectiveness.
Image of Clinical Research Site in Phoenix, United States.

AVP-786

Behavioural Intervention

Verified
Recruiting1 awardPhase 3
This trial tests a combination of two drugs taken by mouth to help calm severe agitation in people with Alzheimer's disease by balancing brain chemicals.
Image of Barrow Neurological Institute /ID# 240388 in Phoenix, United States.

ABBV-916

Verified
Recruiting0 awardsPhase 2
This trial is testing a new drug called ABBV-916 to see if it can help people aged 50-90 who are in the early stages of Alzheimer's disease. Participants will receive the drug regularly over several months. The study aims to find out if the drug is safe and effective by monitoring changes in symptoms and side effects.
Image of University of Alabama, Birmingham in Birmingham, United States.

Lecanemab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is testing lecanemab, a drug aimed at improving memory and thinking skills in people with early signs of Alzheimer's disease. The drug works by reducing amyloid plaques in the brain, which are believed to contribute to Alzheimer's. Researchers want to see if lecanemab is effective over several years.
Image of Center for Cognitive Health in Portland, United States.

ATH-1017

Recruiting1 awardPhase 2 & 3
This trial is testing the safety and tolerability of fosgonimeton in Alzheimer's patients who have completed other studies.
Image of Clinical Trial Site in Staten Island, United States.

KarXT +1 More

Behavioural Intervention

Recruiting1 awardPhase 3
This trial is testing KarXT, a medication, to see if it can prevent psychotic symptoms from returning in people with Alzheimer's Disease. It works by balancing brain chemicals that cause hallucinations and delusions. KarXT has shown positive results in reducing symptoms of schizophrenia.
Image of Clinical Research Site in Santa Ana, United States.

AXS-05

Behavioural Intervention

Recruiting1 awardPhase 3
This trial is testing a new drug for Alzheimer's patients who experience agitation. The goal is to see if it is safe and effective long-term.
Image of UT Arlington - Science and Engineering Innovation and Research Building in Arlington, United States.

Transcranial Photobiomodulation helmet (Neuradiant 1070 Plus) with no light administered +1 More

Device

Recruiting0 awards
This trial aims to study how shining light on the head can affect brain health and cognitive function in the short and long term.
Image of Barrow Neurological Institute in Phoenix, United States.

Sensory Stimulation System (GS120)

Behavioural Intervention

Recruiting1 award
This trial is an extension of a previous study where participants will receive treatment with an Active Sensory Stimulation System for up to 12 months. There will be no sham treatment or randomization in this

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.